M&A: Page 4
-
Natalie Meepian via Getty Images
Merit Medical buys two dialysis catheter lines for $132.5M combined
The acquisitions are expected to boost the Utah-based device maker’s annual revenue by about $30 million.
By Susan Kelly • June 9, 2023 -
Getty Images/Staff via Getty Images
SunMed agrees to $110M takeover of Avanos’ respiratory health unit, continuing M&A spree
Avanos, whose competitors include Stryker and Medline Industries, is selling the unit to narrow its focus on areas where it can succeed.
By Nick Paul Taylor • June 9, 2023 -
Explore the Trendline➔
Permission granted by Roy Mendiola
TrendlineMedTech Dive Outlook 2022
The pandemic continues to disrupt the medical device industry early in 2022, as COVID-19 testing demand remains strong and nonemergent procedures are postponed. In this series, we look at the risks, challenges and opportunities ahead.
By MedTech Dive staff -
Joe Raedle via Getty Images
Novo Nordisk says in talks to acquire French device-maker Biocorp for $165M
The offer per share is about 20% more than Biocorp’s closing stock price on June 2. The two companies plan to focus on drug delivery solutions for chronic diseases, such as diabetes.
By Elise Reuter • Updated June 6, 2023 -
Courtesy of High Purity New England
Getinge will acquire High Purity for as much as $370M to bolster biopharma business
The acquisition is aimed at strengthening Getinge’s position in the fast-growing area of custom single-use solutions for bioprocessing applications.
By Peter Green • May 31, 2023 -
Retrieved from Titan on September 12, 2022
Titan licenses robotic surgery intellectual property to Intuitive after failing to find buyer
After failing to bring its surgical robot to market and getting kicked off the Nasdaq, Titan is now marketing its intellectual property.
By Nick Paul Taylor • May 30, 2023 -
Courtesy of Grail
Illumina accused of ‘playing delay tactics’ to push back EU decision on divesting Grail: Financial Times
Delaying the decision to divest Grail could let Illumina sell the liquid biopsy business when the market is more favorable.
By Nick Paul Taylor • May 30, 2023 -
Courtesy of Boston Scientific
Boston Scientific cancels $230M stent deal after regulators erect barriers to acquisition
The Federal Trade Commission said Boston Scientific took the action in response to investigations by its staff and overseas enforcement partners.
By Nick Paul Taylor • May 26, 2023 -
Neilson Barnard via Getty Images
Illumina chair loses to Icahn pick as proxy battle ends
The decision to replace board Chair John Thompson could change the company’s course as it decides whether to divest liquid biopsy company Grail.
By Elise Reuter • Updated May 25, 2023 -
Permission granted by Medtronic
Medtronic posts profit, sales growth in Q4, agrees to buy Korean diabetes patch maker
The company is “confident in delivering durable revenue growth in the year ahead” amid continued improvements in procedure volumes.
By Peter Green • May 25, 2023 -
Medtronic agrees to buy Korean insulin patch pump maker for $738m to boost diabetes business
The tubeless, disposable insulin patch made by EOFlow will be integrated into Medtronic’s MiniMed 780G system.
By Elise Reuter • May 25, 2023 -
Courtesy of Boston Scientific
A Boston Scientific purchase of Shockwave could be transformative — but at what price?
Boston Scientific has used “tuck-in” acquisitions to boost growth in the past. Some analysts say it should stay the course amid a report the company may make a bid.
By Susan Kelly • May 19, 2023 -
Courtesy of Grail
Icahn bolstered by another proxy advisor in battle with Illumina
The DNA-sequencing company defended its board chair, John Thompson, and drew attention to a new disclosure that Icahn’s firm is being investigated by the U.S. attorney for the Southern District of New York.
By Susan Kelly • Updated May 15, 2023 -
Tim Boyle via Getty Images
Baxter to sell biopharma solutions unit for $4.25B to private equity
The company said it plans to use the proceeds of the sale to pay down its debt.
By Elise Reuter • May 8, 2023 -
HadelProductions via Getty Images
Globus shareholders approve share issuance for $3.1B NuVasive purchase
NuVasive’s shareholders also OK’d the merger agreement, bringing the deal a step closer to closing.
By Elise Reuter • April 28, 2023 -
Courtesy of Quest Diagnostics
Quest Diagnostics to pay $450M to buy liquid biopsy cancer test developer as Q1 revenue drops
The laboratory services provider said patients are returning to the healthcare system for routine care, but COVID testing has plummeted as the pandemic winds down.
By Susan Kelly • April 27, 2023 -
Courtesy of Boston Scientific
Boston Scientific considering purchase of Shockwave Medical: Bloomberg
The acquisition, which would be Boston Scientific’s largest in recent history, would add to the company’s cardiac portfolio.
By Elise Reuter • April 21, 2023 -
Zhanna Hapanovich via Getty Images
Alphatec buys robotic spine navigation system for $55M
The spine surgery specialist expects the robotic platform to begin generating revenue in 2025.
By Susan Kelly • Updated April 21, 2023 -
Michael Nagle via Getty Images
Illumina slaps back at Icahn’s board nominees, opens proxy collection
The fight continues as Illumina aims to block Icahn’s nominees from ousting its CEO and board chair.
By Peter Green • April 20, 2023 -
Maks_Lab via Getty Images
Medtech buyouts by private equity in Q4 shed light on deal-making trends in 2023: report
Medtech companies are continuing to spin off assets to realign portfolios, creating opportunities for private equity firms to buy businesses and exit existing investments.
By Nick Paul Taylor • April 11, 2023 -
Courtesy of Bioventus (composite by MedTech Dive)
Bioventus CEO departs after CartiHeal acquisition unravels
Ken Reali was asked to leave after a deal to buy CartiHeal fell apart. Bioventus’ share price has fallen more than 90% in the past two years.
By Susan Kelly • April 6, 2023 -
Mat Szwajikos via Getty Images
Icahn ramps up rhetoric on Illumina after FTC orders Grail sale
In a letter to Illumina shareholders, Icahn says the two companies “should be separated immediately” to protect “long term growth prospects.”
By Peter Green • April 5, 2023 -
Courtesy of Evident/Olympus
Bain acquires Olympus life sciences unit for $3.1B
The company aims to expand its position as a workflow solution provider in life science and industrial markets.
By Susan Kelly • April 3, 2023 -
Neilson Barnard via Getty Images
Illumina urges shareholders to reject Icahn board nominees
The DNA-sequencing company says Icahn’s board nominees don’t understand its business or the regulatory process.
By Susan Kelly • March 31, 2023 -
Courtesy of Medtronic
ICU Medical challenges GE HealthCare for Medtronic units valued at $8B: report
Medtronic wants to spin off or sell the two units to focus on faster-growing parts of its business and is talking to potential buyers.
By Nick Paul Taylor • March 30, 2023 -
SeventyFour via Getty Images
SonderMind acquires technology from Mindstrong ahead of digital health startup’s shutdown
Mindstrong’s collapse comes in a turbulent period for the digital health sector.
By Nick Paul Taylor • March 23, 2023
Previous
